LDR CEO Christophe Lavigne sold 25,000 shares of the company's stock on the open market yesterday.
The stock was priced at $28 per share, for a total of $700,000 transaction. Mr. Lavigne now owns around 983,000 shares of the company's stock valued around $27.5 million. Stock price opened at $37.14 on Aug. 27 with a market cap of $354.5 million.
The company's 52-week high is $53.51 and low is $34.95. LDR COO James Burrows sold around 19,000 shares on the open market earlier in August, after Piper Jaffray analysts raised their price from $38 to $40 per share and giving the company an "overweight" rating.
Meanwhile, RBC Capital initiated LDR coverage in June with an "outperform" rating and $34 target price.
More articles on orthopedic devices:
Amedica names Dr. B. Sonny Bal chairman of the board
8 predictions on the advanced orthopedic technologies market through 2019
French surgeon performs first spine surgery using Expanding Orthopedics' FLXfit